Logo image of STSS

SHARPS TECHNOLOGY INC (STSS) Stock Fundamental Analysis

NASDAQ:STSS - Nasdaq - US82003F2002 - Common Stock - Currency: USD

5.44  +0.43 (+8.58%)

After market: 5.3201 -0.12 (-2.2%)

Fundamental Rating

1

STSS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. STSS may be in some trouble as it scores bad on both profitability and health. STSS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year STSS has reported negative net income.
STSS had a negative operating cash flow in the past year.
In the past 5 years STSS always reported negative net income.
In the past 5 years STSS always reported negative operating cash flow.
STSS Yearly Net Income VS EBIT VS OCF VS FCFSTSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

STSS's Return On Assets of -127.10% is on the low side compared to the rest of the industry. STSS is outperformed by 86.10% of its industry peers.
STSS has a worse Return On Equity (-465.72%) than 87.70% of its industry peers.
Industry RankSector Rank
ROA -127.1%
ROE -465.72%
ROIC N/A
ROA(3y)-83.26%
ROA(5y)-86.74%
ROE(3y)-212.63%
ROE(5y)-179.23%
ROIC(3y)N/A
ROIC(5y)N/A
STSS Yearly ROA, ROE, ROICSTSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for STSS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STSS Yearly Profit, Operating, Gross MarginsSTSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, STSS has more shares outstanding
The number of shares outstanding for STSS has been increased compared to 5 years ago.
Compared to 1 year ago, STSS has a worse debt to assets ratio.
STSS Yearly Shares OutstandingSTSS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2K 4K 6K
STSS Yearly Total Debt VS Total AssetsSTSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -9.84, we must say that STSS is in the distress zone and has some risk of bankruptcy.
STSS's Altman-Z score of -9.84 is on the low side compared to the rest of the industry. STSS is outperformed by 80.75% of its industry peers.
STSS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.84
ROIC/WACCN/A
WACCN/A
STSS Yearly LT Debt VS Equity VS FCFSTSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.61 indicates that STSS may have some problems paying its short term obligations.
With a Current ratio value of 0.61, STSS is not doing good in the industry: 93.05% of the companies in the same industry are doing better.
A Quick Ratio of 0.25 indicates that STSS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.25, STSS is doing worse than 95.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.25
STSS Yearly Current Assets VS Current LiabilitesSTSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

STSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.48%, which is quite impressive.
EPS 1Y (TTM)58.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STSS Yearly Revenue VS EstimatesSTSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 10B 20B 30B
STSS Yearly EPS VS EstimatesSTSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 -1K -2K -3K -4K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

STSS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STSS Price Earnings VS Forward Price EarningsSTSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STSS Per share dataSTSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K -1.5K -2K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for STSS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHARPS TECHNOLOGY INC

NASDAQ:STSS (6/18/2025, 8:00:00 PM)

After market: 5.3201 -0.12 (-2.2%)

5.44

+0.43 (+8.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-14 2024-05-14/amc
Earnings (Next)N/A N/A
Inst Owners6.14%
Inst Owner Change9431.02%
Ins Owners0.06%
Ins Owner Change4.95%
Market Cap5.55M
Analysts82.86
Price TargetN/A
Short Float %11.45%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)0
Avg Revenue beat(4)-100%
Min Revenue beat(4)-100%
Max Revenue beat(4)-100%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.78
P/tB 2.83
EV/EBITDA N/A
EPS(TTM)-2100.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-6.93
FCFYN/A
OCF(TTM)-6.79
OCFYN/A
SpS0
BVpS1.96
TBVpS1.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -127.1%
ROE -465.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-83.26%
ROA(5y)-86.74%
ROE(3y)-212.63%
ROE(5y)-179.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.94%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.25
Altman-Z -9.84
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)192.36%
Cap/Depr(5y)2248.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.55%
OCF growth 3YN/A
OCF growth 5YN/A